Joint Committee of Public Accounts and Audit

Contents

Review of Auditor-General's Reports 1999-00, Second Quarter

List of recommendations

Chapter 2 : Audit Report No. 13 Management of Major Equipment Acquisition Projects, Department of Defence

Recommendation 1

The Committee recommends that the Defence Audit and Program Evaluation Committee ensure that Australian National Audit Office and JCPAA recommendations are monitored and reviewed in a timely manner. (Paragraph 2.27)

Recommendation 2

The Committee recommends that the Australian National Audit Office consider carrying out a follow-up audit, in the next eighteen months to two years, on the management of major Defence acquisition projects.(Paragraph 2.69)

Chapter 3: Audit Report No. 14 Commonwealth Debt Management

Recommendation 3

The Committee recommends that the Australian Office of Financial Management take action to obtain and maintain the high level of in-house expertise required to enhance its own management and to retain control and exercise judgment over external adviser inputs.(Paragraph 3.22)

Recommendation 4

The Committee recommends that the Australian Office of Financial Management put processes in place to monitor risks and identify weaknesses which may impact on the appropriateness or timing of the portfolio benchmark review process.(Paragraph 3.37)

Recommendation 5

The Committee recommends that the Australian Office of Financial Management move as quickly as possible to implement all of the Australian National Audit Office recommendations. (Paragraph 3.82)

Chapter 4: Audit Report No. 24 Commonwealth Management and Regulation of Plasma Fractionation

Recommendation 6

The Committee recommends that the Department of Health and Aged Cares Audit Committee conduct regular internal audits of the Therapeutic Goods Administrations performance, and provide to the Committee by December 2001 an updated status report of the effectiveness of the Therapeutic Goods Administrations implementation of its auditing program of Commonwealth Serum Laboratories compliance with the Code of Good Manufacturing Practice, including the extent to which the Therapeutic Goods Administration is complying with its own procedures and practices for undertaking these audits.(Paragraph 4.30)

Recommendation 7

The Committee recommends that Commonwealth Serum Laboratories be required on a regular basis to provide positive declarations to the Therapeutic Goods Administration regarding the volume, source and final destination of all foreign plasma imported into Australia by the company and processed at its Broadmeadows fractionation plant. (Paragraph 4.31)

Recommendation 8

The Committee recommends that agencies implement administrative arrangements to ensure that the Therapeutic Goods Administration is notified of all Quarantine Entries made by the Australian Quarantine Inspection Service of human blood and blood products imported into Australia.(Paragraph 4.32)

Recommendation 9

The Committee recommends that the Chief Executive Officer of the Department of Health and Aged Care assess the skill base and training needs of its contract managers, and ensure that appropriate legal and technical advice is readily available to them. (Paragraph 4.56)

Recommendation 10

The Committee recommends that the Australian National Audit Office undertake a timely performance audit of the Department of Health and Aged Cares handling of the Plasma Fractionation Agreement extension review. (Paragraph 4.57)

Back to top